Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/1995
12/13/1995EP0686394A1 Use of N-[[5-(naphthales-1-yl)-1,3-dioxan-2-yl]alkyl]acetamide derivatives for the preparation of medicaments for use in the treatment of neurodegenerative disorders
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
12/12/1995US5475034 Adminstering 3-benzoylphenylacetamide derivatives
12/12/1995US5475033 Anti-allergic pharmaceutical composition for ophthalmic topical administration
12/12/1995US5475023 Aqueous pharmaceutical formulations of sodium cromoglycate
12/12/1995US5474985 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
12/12/1995US5474979 Nonirritating emulsions for sensitive tissue
12/12/1995US5474978 Insulin analog formulations
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/09/1995CA2150960A1 Use of n-[[5-(naphthalen-1-yl)-1,3-dioxan-2-yl]alkyl] -acetamide derivatives for the preparation of medicinal products which are useful in the treatment of neurodegenerative disorders
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions
12/07/1995WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684944A1 Coupling product obtained from hystamine and an amino acid
12/06/1995EP0684820A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
12/05/1995US5473100 Hydroxamic acid derivative
12/05/1995US5473077 4-aminopyrrolidine-2,4-substitude independently with carboxylic acid or 5-tetrazolyl for treating nervous system disorders and psychological disorders
12/05/1995US5473067 For controlling ocular hypertension
12/05/1995US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
12/05/1995US5472703 Ophthalmic lens with anti-toxin agent
11/1995
11/30/1995WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions
11/29/1995EP0684043A1 Therapeutic composition for corneal impairment containing a phosphonic acid diester compound
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995CN1112435A Potent pearl eye drops
11/28/1995US5470882 Diphenylsulfide with urea and sulfonates
11/28/1995US5470856 Tetrahydropyrimidine derivatives
11/23/1995WO1995031211A1 Lacrimal gland specific emulsions for topical application to ocular tissue
11/23/1995WO1995031200A1 Pharmaceutical composition for treating glaucoma containing terazosin
11/23/1995CA2187361A1 Pharmaceutical composition for treating glaucoma containing terazosin
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995EP0682514A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
11/22/1995EP0585380B1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
11/22/1995EP0544714B1 Heterocyclic compounds and their preparation and use
11/21/1995US5468897 Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
11/21/1995US5468879 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/21/1995US5468731 Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030642A1 Combinatorial dihydrobenzopyran library
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189634A1 Combinatorial dihydrobenzopyran library
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/15/1995EP0681840A1 Use of phosphate diester for the treatment of retinal diseases
11/15/1995EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof
11/14/1995US5466833 Cyclopenta(b)furan intermediates
11/14/1995US5466826 Process for preparing a physical form of pharmaceutical agent
11/14/1995US5466690 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
11/14/1995CA1337565C Procyanidol oligomeric fractions, the processes for the preparation thereof and pharmaceutical compositions containing them
11/11/1995CA2147587A1 Method and composition for prophylaxis and treatment of retinal diseases
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/08/1995EP0680337A1 Methods and compositions for the direct concentrated delivery of passive immunity
11/08/1995EP0502143B1 Composition for treating ocular pain
11/08/1995CN1111148A Acupoint application for myopia
11/07/1995US5464821 And intraocular hypertension
11/02/1995WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029164A1 Novel sulfur-containing amino acid derivative
11/02/1995WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/02/1995WO1995028941A1 Composition and method for treatment of cmv infection
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995EP0679630A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
10/1995
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5463074 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
10/31/1995US5462968 EP2 -receptor agonists as agents for lowering intraocular pressure
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/29/1995CA2146885A1 Therapeutic composition for corneal impairment
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028166A2 Method for implanting encapsulated cells in a host
10/26/1995CA2187335A1 Method for implanting encapsulated cells in a host
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678016A1 Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor
10/25/1995EP0406413B1 Scanning type tunnel microscope
10/25/1995CN1110597A Vision recovery capsule
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995US5459133 Alpha-2 adrenergic agonists, treatment of age related loss of accommodation
10/17/1995US5458883 Method of treating disorders of the eye
10/17/1995CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
10/17/1995CA1337344C Benzamino aromatic compounds, preparation process and use in cosmetics
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026734A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026712A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995WO1995026711A1 Ophthalmic composition with decreased viscosity
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 531